Nanxin Pharmaceutical: Guangzhou Qianyuan plans to reduce its shareholding in the company by no more than 3%.

On September 24th, Nanxin Pharmaceutical announced that its shareholder, Guangzhou Qianyuan Investment Consulting Partnership Enterprise, which holds 15.71% of the company's shares, plans to reduce its holdings by no more than 8.232 million shares, or no more than 3% of the company's total share capital, through centralized bidding and block trading due to fund needs.